US Patent 11071289 DNA knock-in system
Patent 11071289 was granted and assigned to Biocytogen on July, 2021 by the United States Patent and Trademark Office.
All edits
Edits on 12 Dec, 2023
Golden AI
Edits made to:
Article (+394 characters)
Article
Patent abstract
The present disclosure relates to an efficient genome editing technique. In one aspect, the technique can greatly improve the efficiency of homologous recombination during intracellular targeting, including gene targeting. Using this technique, genetically modified cell lines, rat, mouse, zebrafish, and fertilized eggs of other species can be quickly and efficiently generated.
Edits on 21 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 28 Apr, 2023
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
110712890
Date of Patent
July 27, 2021
0Patent Application Number
155036950
Date Filed
August 13, 2015
0Official Website
Patent Primary Examiner
Edits on 25 Sep, 2022
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
110712890
Date of Patent
July 27, 2021
0Patent Application Number
155036950
Date Filed
August 13, 2015
0Official Website
Patent Primary Examiner
Edits on 6 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 13 Feb, 2022
Golden AI
Edits made to:
Infobox (+9 properties)
US Patent 11071289 DNA knock-in system
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
11071289
Date of patent
July 27, 2021
Patent application number
15503695
Date Filed
August 13, 2015
Patent primary examiner
Find more entities like US Patent 11071289 DNA knock-in system
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.